A Clinical Study Shows the Theracurmin®’s Safety and Potential Role in Improving Quality of Life [View all]
This discussion thread was locked as off-topic by Rhiannon12866 (a host of the Latest Breaking News forum).
Source: BusinessWire, Pharmiweb, and Cancer Chemother Pham
Overall Theracurmin® did not increase the risk of adverse events on 16 advanced pancreatic or biliary tract cancer patients receiving palliative chemotherapy even at relatively high dosage levels. (200mg/day and 400 mg/day as curcumin)
Theracurmin® administration produced significant high blood concentrations in a dose dependent fashion proving its high absorption capabilities. The median plasma curcumin level 2 hours after Theracurmin® intake were significantly higher than the median value of the previous study using 8 g of conventional curcumin.
Theracurmin® administration demonstrated considerable improvement of QOL scores including fatigue score functional (emotional role cognitive physical and social functions) score and appetite loss score.
The median survival time (MST) was 132 days and three patients (21%) survived more than 12 months. Given that dismal prognosis of patients enrolled in this study these results are quite promising.
Read more: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74543#.UaBNNkq5XGg
= new reply since forum marked as read